# Filing Detail

Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
SEC Accession No. 0001213900-21-002942
Filing Date
2021-01-20
Accepted
2021-01-19 17:33:26
Documents
25

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | AMENDMENT NO. 5 TO FORM F-1 | ea133431-f1a5_nlspharma.htm | F-1/A | 2082569
2 | FORM OF UNDERWRITING AGREEMENT BY AND AMONG NLS PHARMACEUTICS LTD. AND THE UNDER | ea133431ex1-1_nlspharma.htm | EX-1.1 | 437305
3 | AMENDMENT NUMBER 4 TO CONVERTIBLE LOAN AGREEMENT DATED FEBRUARY 21, 2020 BETWEEN | ea133431ex10-29_nlspharma.htm | EX-10.29 | 17496
4 | AMENDMENT NUMBER 2 TO BRIDGE LOAN AGREEMENT BETWEEN NLS PHARMACEUTICS LTD. AND M | ea133431ex10-30_nlspharma.htm | EX-10.30 | 29512
5 | AMENDMENT NUMBER 3 TO BRIDGE LOAN AGREEMENT BETWEEN NLS PHARMACEUTICS LTD. AND M | ea133431ex10-31_nlspharma.htm | EX-10.31 | 21337
6 | FORM OF ADDENDUM NUMBER 4 TO PROMISSORY NOTE DATED JANUARY 2019 BETWEEN CERTAIN | ea133431ex10-32_nlspharma.htm | EX-10.32 | 14323
7 | ADDENDUM NUMBER 4 TO CREDIT FACILITY DATED AUGUST 31, 2015 BETWEEN NLS PHARMA AG | ea133431ex10-33_nlspharma.htm | EX-10.33 | 21929
8 | ADDENDUM NUMBER 4 TO CREDIT FACILITY DATED AUGUST 31, 2015 BETWEEN NLS-1 PHARMA | ea133431ex10-34_nlspharma.htm | EX-10.34 | 54351
9 | ADDENDUM NUMBER 4 TO CONVERTIBLE PROMISSORY NOTE DATED JANUARY 18, 2019 BETWEEN | ea133431ex10-35_nlspharma.htm | EX-10.35 | 18127
10 | CONSENT OF MARCUM LLP | ea133431ex23-1_nlspharma.htm | EX-23.1 | 3160
11 | REGISTRANT'S REPRESENTATION PURSUANT TO REQUIREMENTS OF FORM 20-F, ITEM 8.A.4 | ea133431ex99-3_nlspharma.htm | EX-99.3 | 10752
12 | GRAPHIC | image_001.jpg | GRAPHIC | 14073
13 | GRAPHIC | image_004a.jpg | GRAPHIC | 30789
14 | GRAPHIC | image_005.jpg | GRAPHIC | 34402
15 | GRAPHIC | image_006.jpg | GRAPHIC | 14916
16 | GRAPHIC | image_007.jpg | GRAPHIC | 17745
17 | GRAPHIC | image_008.jpg | GRAPHIC | 11253
18 | GRAPHIC | image_009.jpg | GRAPHIC | 22650
19 | GRAPHIC | image_010.jpg | GRAPHIC | 15414
20 | GRAPHIC | image_011.jpg | GRAPHIC | 18536
21 | GRAPHIC | image_012.jpg | GRAPHIC | 23274
22 | GRAPHIC | image_013.jpg | GRAPHIC | 46910
23 | GRAPHIC | image_014.jpg | GRAPHIC | 13369
24 | GRAPHIC | image_015.jpg | GRAPHIC | 46220
25 | GRAPHIC | image_016.jpg | GRAPHIC | 95983
| Complete submission text file | 0001213900-21-002942.txt |  | 3272163

Mailing Address ALTER POSTPLATZ 2 STANS V8 CH-6370
Business Address ALTER POSTPLATZ 2 STANS V8 CH-6370 41-79-779-60-00
NLS Pharmaceutics Ltd. (Filer) CIK: 0001783036 (see all company filings)

EIN.: 000000000 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: F-1/A | Act: 33 | File No.: 333-236797 | Film No.: 21536592
SIC: 2834 Pharmaceutical Preparations